EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

GN Store Nord A/S (0K9P) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of GN Store Nord A/S DKK 33.06, price DKK 105, upside -68.6%, quality 51 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · GB · Home Denmark · ISIN DK0010272632

GS Thin data Sep 24, 2026

GN Store Nord A/S

0K9P · LSE

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value kr 33.06 · Strongly overvalued (−68.6%)
!Quality 51/100
!Mixed Growth (revenue 3y +12.0 %/yr)
!Loss over the last twelve months · -2.3% net margin (TTM) · fiscal year 2020 9.3%
!Moderate debt
!Narrow moat 32/100
!Evidence only low, so the estimate is less certain
!The models disagree: range kr 14.97 to kr 57.19

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 576.68 kr 83.31 Fair Value kr 33.06 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range kr 83.31 – kr 576.68 · fair‑value band kr 14.97 – kr 57.19 · the kr 105.28 price screens above the kr 33.06 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, Europe, North America, and internationally. The company operates through Hearing, Enterprise, and Gaming segments. The Hearing segment produces and sells hearing instruments and products. The Enterprise segment supplies audio and video devices for professional use.

Show more

GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, Europe, North America, and internationally. The company operates through Hearing, Enterprise, and Gaming segments. The Hearing segment produces and sells hearing instruments and products. The Enterprise segment supplies audio and video devices for professional use. The Gaming segment produces gaming devices and peripherals. It offers its products under the ReSound, Beltone, Interton, Danavox, Jabra Enhance, Jabra, BlueParrott, FalCom, SteelSeries, and KontrolFreek brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.

Stock analysis

GN Store Nord A/S (0K9P) currently trades at kr 105.28, while our model-based Fair Value estimate is kr 33.06, 68.6% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of kr 49.57 per share, and 0 of the 25 models we run sit above the kr 105.28 price.

Bear case: the Dividend Discount group reads lowest at kr 6.60, and 25 of the 25 models stay below the price. Evidence for this calculation is low.

Scenario range: kr 14.97 (bear) to kr 57.19 (bull), the price of kr 105.28 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

GN Store Nord A/S reported revenue of 13.4B DKK in FY2020 versus 8.7B DKK in FY2016, a compound +11.7%/yr. Reported net income was 1.3B DKK in FY2020, compounding +4.9%/yr from FY2016.

Key figures

Market cap 50.2B DKK (≈ $7.6B) · P/S ratio 3.02 · Dividend yield 0.4% · Net margin 9.3% · Return on equity 3.0% · Return on assets (EBIT) 12.0% · Operating margin −22.5% · Revenue (TTM) 16.6B DKK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (medium confidence).

What moves the price

The share trades about 11% below its 52-week high and 22% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −69%, 0K9P screens richer than that median.

Fair Value models

Bear kr 14.97 Fair Value kr 33.06 Bull kr 57.19
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV kr 20.78 kr 25.19 kr 29.00 74
FCF DCF kr 8.69 kr 20.35 kr 39.56 71
Growth DCF kr 8.58 kr 19.26 kr 36.22 70
All 25 models by family
DCF Models
FCF DCF kr 8.69 kr 20.35 kr 39.56 71
5Y Revenue Exit kr 18.39 kr 40.30 kr 70.31 66
5Y EBITDA Exit kr 29.21 kr 62.35 kr 104.14 69
5Y P/E Exit kr 24.50 kr 52.74 kr 85.03 65
10Y Revenue Exit kr 13.79 kr 33.12 kr 63.07 59
10Y EBITDA Exit kr 21.77 kr 48.80 kr 90.44 61
10Y P/E Exit kr 18.73 kr 41.97 kr 74.98 58
Earnings-Based
Graham-Dodd kr 17.87 kr 79.55 kr 108.97 61
Lynch FV kr 20.66 kr 29.51 kr 38.36 58
PEG = 1.0 kr 20.66 kr 29.51 kr 38.36 55
EPV kr 20.78 kr 25.19 kr 29.00 74
Dividend Discount
Gordon GGM kr 3.83 kr 7.64 kr 11.57 64
DDM Multi-Stage kr 3.83 kr 6.60 kr 8.06 64
Multiples
P/E Multiple kr 43.36 kr 57.81 kr 72.26 63
P/S Multiple kr 33.50 kr 44.67 kr 55.84 58
P/B Multiple kr 33.50 kr 44.67 kr 55.84 55
EV/EBIT kr 36.38 kr 50.89 kr 65.40 66
EV/EBITDA kr 43.97 kr 61.01 kr 78.05 67
EV/Revenue kr 23.91 kr 37.23 kr 50.55 53
Asset-Based
NCAV (Graham) kr 5.43 kr 7.28 kr 10.87 54
Growth DCF
Growth DCF kr 8.58 kr 19.26 kr 36.22 70
Rev-Margin DCF kr 18.39 kr 39.51 kr 66.36 66
Economic Profit
Residual Income kr 15.61 kr 21.42 kr 40.66 69
ROIC Compounder kr 23.92 kr 34.15 kr 47.45 68
Growth Earnings
Growth-Adj P/E kr 34.70 kr 49.57 kr 64.44 65

Open the full fair value analysis →

Notify me when 0K9P reaches fair value

Put 0K9P on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 51/100

Of which business quality 52 · Market factors (momentum, volatility) 41

Profitability 64
Margins and returns on capital today
Quality Growth 39
Are margins and returns improving?
Cashflow 43
Earnings quality: real cash, not paper profit
Fin. Strength 45
Balance sheet, leverage, solvency risk
Investment 75
Disciplined investing over empire-building
Low Volatility 32
Calm price path (market factor)
Momentum 45
Price trend over the last 3–12 months (market factor)
52W Momentum 43
Distance to the 52-week high (market factor)

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 64/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+7.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
16.7% (2016) → 12.1% (2020)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
not computed

0K9P screens overvalued: fair value 69% below the price. Compare with Abbott Laboratories, →

Compare GN Store Nord A/S with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 347 stocks

Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 51 · Above median
Fair Value upside −65.3% · Bottom 25%
Profitability
Return on equity (TTM) 3.0% · Above median
Return on assets 2.5% · Above median
Net margin (TTM) −2.3% · Below median
Operating margin (TTM) −22.5% · Bottom 25%
Growth and dividend
Revenue growth −8.2% · Bottom 25%
Dividend yield (TTM) 0.4% · Bottom 25%
Balance sheet
Debt / equity 0.98× · Highest 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 1.51× · Cheaper than median
P/S (TTM) 0.47× · Cheapest 25%
EV/EBITDA 7.6× · Cheapest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $98.83 $74.79 −24%
Medtronic plc MDT $87.09 $65.61 −25%
Stryker Corporation SYK $278.77 $306.65 +10%
Boston Scientific Corporation BSX $43.65 $48.02 +10%
Edwards Lifesciences Corporation EW $85.19 $81.94 −4%
Siemens Healthineers AG SHL €37.86 €35.19 −7%
DexCom, Inc DXCM $86.68 $95.35 +10%
GE HealthCare Technologies Inc GEHC $66.63 $70.37 +6%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥153.86 ¥169.25 +10%
Koninklijke Philips N.V PHIA €21.87 €15.23 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "GN Store Nord A/S Fair Value". https://www.fairvalue-calculator.com/stock/0K9P

Frequently asked questions

Is GN Store Nord A/S (0K9P) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of kr 33.06 versus a price of kr 105.28, about −69% upside (overvalued).
What is the fair value of 0K9P?
Our model-based fair value for GN Store Nord A/S is kr 33.06 (as of Sep 24, 2026), built from audited fundamentals. The current price: kr 105.28.
What is the quality score of 0K9P?
GN Store Nord A/S has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for GN Store Nord A/S (0K9P)?
Our model-based price target is the fair value of kr 33.06 (as of Sep 24, 2026) from 25 valuation models. Cautious scenario kr 14.97, optimistic scenario kr 57.19. It is a calculation from audited fundamentals, not an analyst target.
What is the GN Store Nord A/S stock forecast for 2026?
Our models put fair value at kr 33.06, about −69% upside versus a price of kr 105.28 (overvalued). Cautious scenario kr 14.97, optimistic scenario kr 57.19. The calculation is refreshed regularly with new filings.
What is the revenue of GN Store Nord A/S (0K9P)?
GN Store Nord A/S reported trailing-twelve-month revenue of about 16.6B DKK (latest available figure, as of Sep 24, 2026).
Does GN Store Nord A/S pay a dividend?
GN Store Nord A/S currently shows a dividend yield of about 0.41% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of GN Store Nord A/S (0K9P)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For GN Store Nord A/S it is kr 33.06 per share (as of Sep 24, 2026), against a price of kr 105.28. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is GN Store Nord A/S stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0K9P trades above its calculated fair value: price kr 105.28, fair value kr 33.06, a gap of about −69% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0K9P?
No. The price is what the market pays today (kr 105.28); the fair value is what the company's own numbers justify (kr 33.06). For GN Store Nord A/S the two are kr 72.22 per share apart. That gap is exactly why we show both numbers side by side.
How much is GN Store Nord A/S worth?
The market values GN Store Nord A/S at about 50.2B DKK (market capitalisation, as of Sep 24, 2026). Per share that is kr 105.28; our models calculate a fair value of kr 33.06 per share.
What do the bullish and bearish scenarios say about 0K9P?
Our models span a range for GN Store Nord A/S: cautious scenario kr 14.97, base kr 33.06, optimistic kr 57.19 per share (as of Sep 24, 2026, price kr 105.28). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of GN Store Nord A/S (0K9P)?
Balance-sheet figures for GN Store Nord A/S (as of Sep 24, 2026): return on equity 3.0%, debt of 0.98 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 0K9P from its 52-week high?
GN Store Nord A/S trades at kr 105.28, about 11% below its 52-week high of kr 118.95 and 22% above the low of kr 86.60 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of kr 33.06 is for.
Which stocks are comparable to GN Store Nord A/S?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is GN Store Nord A/S stock attractive at the current price?
The data as of Sep 24, 2026: price kr 105.28, calculated fair value kr 33.06 (−69%), Quality Score 51/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0K9P calculated?
We run GN Store Nord A/S through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 33.06, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. GN Store Nord A/S itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of GN Store Nord A/S (0K9P)?
The closing price on Oct 2, 2026 was kr 105.28. Our model-based fair value is kr 33.06, about −69% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with GN Store Nord A/S right now?
The price sits above even our optimistic bull case (kr 57.19). The favourable scenario is already priced in. The model range is unusually wide (kr 14.97 to kr 57.19). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of GN Store Nord A/S

How large is the market capitalisation of GN Store Nord A/S (0K9P)?
The market capitalisation of GN Store Nord A/S is 50.2B DKK (≈ $7.6B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of GN Store Nord A/S (0K9P)?
The price-to-sales ratio of GN Store Nord A/S is 3.02 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of GN Store Nord A/S (0K9P)?
The dividend yield of GN Store Nord A/S is 0.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of GN Store Nord A/S (0K9P)?
The net margin of GN Store Nord A/S is 9.3% (fiscal year 2020). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of GN Store Nord A/S (0K9P)?
The return on equity (ROE) of GN Store Nord A/S is 3.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of GN Store Nord A/S (0K9P)?
On an EBIT basis the return on assets of GN Store Nord A/S is 12.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of GN Store Nord A/S (0K9P)?
The operating margin of GN Store Nord A/S is −22.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at GN Store Nord A/S (0K9P)?
Revenue at GN Store Nord A/S is growing −8.2% versus a year earlier (3y avg +12.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at GN Store Nord A/S (0K9P)?
Earnings per share at GN Store Nord A/S are growing −6.5% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch GN Store Nord A/S in the live analysis

One click puts GN Store Nord A/S on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.